IRIDEX Other Non-Current Liabilities 2012-2026 | IRIX

IRIDEX other non-current liabilities from 2012 to 2026. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
IRIDEX Annual Other Non-Current Liabilities
(Millions of US $)
2025 $0
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $1
2017 $1
2016 $1
2015 $1
2014 $1
2013 $0
2012 $1
2011 $1
IRIDEX Quarterly Other Non-Current Liabilities
(Millions of US $)
2026-03-31 $0
2025-12-31 $0
2025-09-30 $0
2025-06-30 $0
2025-03-31 $0
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $1
2018-12-31 $1
2018-09-30 $1
2018-06-30 $1
2018-03-31 $1
2017-12-31 $1
2017-09-30 $1
2017-06-30 $0
2017-03-31 $0
2016-12-31 $1
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $1
2015-03-31 $1
2014-12-31 $1
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $1
2012-12-31 $1
2012-09-30 $1
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $1
Sector Industry Market Cap Revenue
Computer and Technology Laser Systems and Components $0.017B $0.053B
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
Stock Name Country Market Cap PE Ratio
IPG Photonics (IPGP) United States $5.404B 89.66
Applied Energetics (AERG) United States $0.246B 0.00